Global Pharmaceutical Sales Force - PowerPoint PPT Presentation

About This Presentation
Title:

Global Pharmaceutical Sales Force

Description:

Easy-to-use web-based database enables users to generate custom reports based upon any combination of these variables: Brand, Therapeutic area, Company, Country and Time period. – PowerPoint PPT presentation

Number of Views:516

less

Transcript and Presenter's Notes

Title: Global Pharmaceutical Sales Force


1
Global Pharmaceutical Sales ForceDeployment
AnalyzerEurope, India, Japan, Latin Americaand
the United States

2
GLOBAL PHARMACEUTICALSALES FORCEDEPLOYMENT
ANALYZER CAPABILITIES
1
3
About PharmaForce International
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT
ANALYZER CAPABILITIES
  • Specialists in multi-client (syndicated) and
    proprietary sales, marketing and medical
    benchmarking and market research for the
    pharmaceutical and biotech industries
  • Global leaders in identifying everything and
    anything that pharmaceutical companies want to
    know about the operations of their competitors
    and perspectives of their customers
  • Multi-lingual staff with direct experience in the
    pharmaceutical industry and business intelligence
  • Hundreds of years of combined industry experience
    as District Managers, Product Managers, Medical
    Information Specialists, Market Research
    Directors, Training Managers and Country Business
    Unit Directors

2
4
Field-Tested Primary Source Research Approach
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT
ANALYZER CAPABILITIES
  • More than 90 of the information for any project
    is derived from one-on-one interviews with
    individuals in the industry, including current
    and former employees of the target organizations
  • Interviewers draw upon their knowledge and
    personal experiences in the industry to form a
    common bond with interview targets and engage in
    peer-to-peer discussions about topics of common
    interest
  • Supplemented with exhaustive searches of all
    relevant electronic and printed databases,
    including PharmaForces proprietary databases
    developed over the past decade
  • Database of qualified contacts in the
    pharmaceutical industry exceeds 45,000
  • Includes personnel in almost every sales and
    marketing function from sales representatives to
    senior management
  • Systematic, ongoing process to add new contacts

3
5
Field-Tested Primary Source Research Approach
(contd)
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT
ANALYZER CAPABILITIES
  • Typically, 25 of interviewees participate
    willingly, while another 25 refuse to
    participate
  • Strong interviewing skills come into play with
    the middle 50 as key partial pieces of data are
    culled from their limited responses
  • Ability to trade data on previously-researched
    companies dramatically increases the level of
    cooperation
  • One-on-one discussions with multiple
    knowledgeable sources result in verification of
    data
  • Outliers are quickly identified and assimilated
    through more interviews

4
6
Field-Tested Primary Source Research Approach
(contd)
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT
ANALYZER CAPABILITIES
  • Triangulation of data from contacts who are
    customers, suppliers and target company employees
    results in multiple confirmations of findings
    from all possible perspectives
  • Previous research experience on the topics allows
    for the widest possible knowledge base of the
    target deliverables and key resources

5
7
About the Global Deployment Analyzer
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT
ANALYZER CAPABILITIES
  • Based on client requests for timely and accurate
    deployment and marketed product information,
    PharmaForce International developed the Global
    Pharmaceutical Sales Force Deployment Analyzer
  • Powerful web-based database program that covers
    the deployment of leading pharmaceutical
    companies sales forces in the United States,
    Europe, India, Japan and selected Latin American
    countries
  • Easy-to-use database contains up-to-date
    information on leading companies in Europe,
    India, Japan , Argentina, Brazil , Mexico and the
    United States
  • Continuously-updated database
  • As PharmaForce receives new or revised data on
    each of the target companies, the new data will
    be immediately added to the database
  • No waiting for the next quarterly or yearly
    installment

6
8
About the Global Deployment Analyzer (contd)
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT
ANALYZER CAPABILITIES
  • Available database programs
  • European Deployment Analyzer database
  • Introduced in 2003
  • Information about 25 leading pharmaceutical
    companies sales forces
  • Japan Deployment Analyzer database
  • Launched in 2009
  • Information about 26 leading pharmaceutical
    companies sales forces
  • U.S. Deployment Analyzer database
  • Introduced in 2008
  • Information about over 60 leading pharmaceutical
    companies sales forces

7
9
About the Global Deployment Analyzer (contd)
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT
ANALYZER CAPABILITIES
  • India Deployment Analyzer database
  • Introduced in 2012
  • Information about 12 leading pharmaceutical
    companies sales forces
  • Latin America Deployment Analyzer database
  • Introduced in 2012
  • Information about 13 companies in Argentina,
    Brazil and Mexico

8
10
About the Global Deployment Analyzer (contd)
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT
ANALYZER CAPABILITIES
  • Easy-to-use web-based database enables users to
    generate custom reports based upon any
    combination of the following variables
  • Brand
  • Therapeutic area
  • Company
  • Country
  • Time period

9
11
About the Global Deployment Analyzer (contd)
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT
ANALYZER CAPABILITIES
  • Data available in the Deployment Analyzer
    includes
  • Total number of company Sales Representatives
    deployed by sales group
  • Primary Care
  • Specialty/Hospital
  • Number of Sales Representatives by therapeutic
    area
  • Number of Sales Representatives (Full-Time
    Equivalents/FTEs) supporting individual brands
  • Based on relative effort reported by company
    personnel in interviews
  • Product priorities by each
  • Sales group
  • Sales force (U.S. only)
  • Therapeutic area

10
12
About the Global Deployment Analyzer (contd)
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT
ANALYZER CAPABILITIES
  • Average salaries and bonuses
  • Data available in the U.S. and Japan Deployment
    Analyzers also includes
  • Total number of District Managers, Regional
    Managers and other sales management by
    group/division as defined by the target company
  • Sales group organizational structures
  • Call Reach Frequency Analysis

11
13
Comprehensive List of Therapeutic Areas Covered
in the Database
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT
ANALYZER CAPABILITIES
  • Anti-Infectives (includes antibiotics,
    anti-fungals anti-virals)
  • Cardiovascular
  • CNS, Pain and Anesthesia
  • Dermatology
  • Endocrinology and Metabolic Disorders
  • Gastrointestinal
  • Gynecology/Womens Health
  • Nephrology and Transplantation
  • Oncology and Hematology
  • Ophthalmology
  • Respiratory and Allergy
  • Rheumatology, Bone and Inflammation
  • Urology
  • Vaccines
  • Other

12
14
EUROPE DEPLOYMENT ANALYZER
13
15
10 Target Countries
EUROPE DEPLOYMENT ANALYZER
  • Austria
  • Belgium
  • France
  • Germany
  • Italy
  • Netherlands
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom

14
16
Target Companies
EUROPE DEPLOYMENT ANALYZER
  • AbbVie (incl. former Solvay)
  • Amgen
  • Astellas
  • AstraZeneca
  • Bayer
  • Biogen Idec
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Celgene
  • Daiichi-Sankyo
  • Eisai
  • Eli Lilly
  • GlaxoSmithKline
  • Janssen
  • Lundbeck
  • Merck Serono
  • Merck Sharp Dohme (incl. former
    Schering-Plough)
  • Novartis
  • Novo Nordisk
  • Pfizer
  • Roche
  • Sanofi (incl. former Genzyme)
  • Takeda (incl. former Nycomed)
  • Teva (incl. former Cephalon)
  • UCB

15
17
INDIA DEPLOYMENT ANALYZER
16
18
Target Companies
INDIA DEPLOYMENT ANALYZER
  • AbbVie
  • Biocon
  • Cipla
  • Dr. Reddy Labs
  • Eli Lilly
  • Fresenius Kabi
  • Lupin
  • Mankind
  • Novartis
  • Pfizer
  • Sanofi
  • Sun

17
19
JAPAN DEPLOYMENT ANALYZER
18
20
Target Companies
JAPAN DEPLOYMENT ANALYZER
  1. AbbVie
  2. Astellas
  3. AstraZeneca
  4. Banyu (incl. former Schering-Plough)
  5. Bayer
  6. Bristol-Myers Squibb
  7. Chugai
  8. Daiichi-Sankyo
  9. Dainippon Sumitomo
  10. Eisai
  11. Eli Lilly
  12. GlaxoSmithKline
  13. Janssen
  1. Kyowa Hakko Kirin
  2. Mitsubishi Tanabe
  3. Nippon Boehringer Ingelheim
  4. Nippon Kayaku
  5. Novartis
  6. Otsuka
  7. Pfizer
  8. Sanofi
  9. Shionogi
  10. Taiho
  11. Taisho Toyama
  12. Takeda
  13. Yakult Honsha

19
21
LATIN AMERICADEPLOYMENT ANALYZER
20
22
Target Companies
LATIN AMERICA DEPLOYMENT ANALYZER
  • AstraZeneca
  • Bayer
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Eli Lilly
  • EMD Serono
  • Genentech/Roche
  • GlaxoSmithKline
  • Janssen
  • Merck
  • Novartis
  • Pfizer
  • Sanofi

21
23
U.S. DEPLOYMENT ANALYZER
22
24
Target Companies
U.S. DEPLOYMENT ANALYZER
  1. AbbVie
  2. Abbott Medical Optics
  3. Actavis (formerly Watson)
  4. Actelion
  5. Alcon (incl. Ciba Vision)
  6. Alexion
  7. Allergan
  8. Allos
  9. Amgen
  10. Astellas (incl. OSI)
  11. AstraZeneca
  12. Auxilium
  13. Bausch Lomb (incl. former Ista)
  14. Baxter
  15. Bayer
  16. Biogen Idec
  17. Boehringer Ingelheim
  1. Bristol-Myers Squibb (incl. former Amylin)
  2. Celgene (incl. former Abraxis Bioscience)
  3. Cooper Vision
  4. Cubist
  5. Daiichi-Sankyo
  6. Eisai
  7. Eli Lilly Company
  8. EMD Serono
  9. Endo (incl. former Indevus)
  10. Ferring
  11. Forest Lab
  12. Fougera Pharmaceutical
  13. Galderma
  14. Genentech/Roche
  15. Gilead
  16. GlaxoSmithKline (incl. former Stiefel)
  17. Ipsen

23
25
Target Companies (contd)
U.S. DEPLOYMENT ANALYZER
  1. Iridex
  2. JJ Ophthalmics/Vistakon
  3. Janssen Biotech (formerly Centocor)
  4. Janssen Pharmaceuticals
  5. Meda
  6. Merck (incl. former Schering-Plough and Inspire)
  7. Merz
  8. Novartis
  9. Novo Nordisk
  10. Onyx Pharmaceuticals
  11. Otsuka
  12. Pfizer (incl. former Wyeth and King)
  13. Purdue
  14. Regeneron
  1. Sanofi (incl. former Genzyme)
  2. Sanofi Pasteur
  3. Shire
  4. Sunovion (formerly Sepracor)
  5. Spectrum (incl. former Allos)
  6. Synergetics
  7. Takeda (incl. former Millennium)
  8. Teva (incl. former Cephalon)
  9. UCB
  10. Valeant (incl. former Medicis and Dermik)
  11. ViiV Healthcare
  12. United Therapeutics
  13. Warner Chilcott

24
26
DATABASE ACCESS
25
27
Access to the Global Deployment Analyzer Database
DATABASE ACCESS
  • Any employee of your organization globally may
    access the Deployment Analyzer at any time, 24
    hours a day
  • Accessible from any computer in the world with
    Internet access
  • Access the Global Pharmaceutical Sales Force
    Deployment Analyzer online at
  • http//www.pharmaforce.biz/
  • Support
  • When logged into the database, pausing the cursor
    over a search button will activate a description
    of the search function
  • Visit the FAQ section in the database for
    questions about our terminology and methodology

26
Write a Comment
User Comments (0)
About PowerShow.com